CAS 1010731-97-1

MLN-3897

CAS: 1010731-97-1

MLN-3897 is a new small molecule that has potent inhibitory activity against chemokine receptors. MLN-3897 blocks chemotaxis of immune cells and viral replication, and is therefore a potential treatment for autoimmune diseases and other inflammatory diseases. It also inhibits the expression of surface proteins on activated T cells, which may be due to its ability to block leukotriene receptor antagonist activity. This drug is currently in preclinical development, but could potentially be deployed as an anti-inflammatory agent in the future.

Pureza: Min. 95%

Ref: 3D-BM177435

MLN-3897

CAS: 1010731-97-1

MLN-3897 is an oral CCR1 antagonist, Ki 2.3 nM, blocks 125I-MIP-1α binding, and inhibits Akt signaling in MM cells.

Fórmula: C₃₀H₃₁ClN₂O₄

Pureza: 98.62%

Cor e Forma: Solid

Peso molecular: 519.03

Ref: TM-T28072